The effects of long term administration of dopamine on renal function in hypertensive patients.
D000328:Adult; D000368:Aged; D000618:Aminohippuric Acids / Q000652:urine; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002986:Clinical Trials as Topic; D004298:Dopamine / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D005919:Glomerular Filtration Rate; D006339:Heart Rate / Q000187:drug effects; D006400:Hematocrit; D006801:Humans; D006973:Hypertension / Q000503:physiopathology*; D007263:Infusions, Parenteral; D007668:Kidney / Q000503:physiopathology*; D007676:Kidney Failure, Chronic / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000097:blood; D011674:Pulse / Q000187:drug effects; D012964:Sodium / Q000097:blood / Q000652:urine; D013997:Time Factors; D014508:Urea / Q000097:blood
D000618:Aminohippuric Acids; D014508:Urea; D012964:Sodium; D011188:Potassium; D004298:Dopamine